Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H1, 2018

2018-04-30
Price :
Published : Apr-2018
No. of Pages : 323
order by fax Inquire before Buying request discount
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) 31
Apr 02, 2018: Symic Bio Announces 12-Month Results from the SHIELD Trial of SB-030 in Peripheral Vascular Disease 31
Mar 05, 2018: Symic Bio Announces Results of Locally-Administered Therapeutic SB-030 in Preclinical Model of Vascular Intervention 31
Clinical Trial Profile Snapshots 32
Appendix 321
Abbreviations 321
Definitions 321
Research Methodology 322
Secondary Research 322
About GlobalData 323
Contact Us 323
Source 323

List of Tables
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Region, 2018* 8
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 16
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 19
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30

List of Figures
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 16
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 19
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30
GlobalData Methodology 322
Filed in: Pharmaceutical
Publisher : GlobalData